157 related articles for article (PubMed ID: 31269290)
1. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
Nam RK; Benatar T; Wallis CJD; Kobylecky E; Amemiya Y; Sherman C; Seth A
Prostate; 2019 Sep; 79(12):1422-1438. PubMed ID: 31269290
[TBL] [Abstract][Full Text] [Related]
2. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
3. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
4. miR-196a-mediated downregulation of p27
Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
[TBL] [Abstract][Full Text] [Related]
5. Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
Bansal N; Mishra PJ; Stein M; DiPaola RS; Bertino JR
Oncotarget; 2015 Jun; 6(17):15321-31. PubMed ID: 26036314
[TBL] [Abstract][Full Text] [Related]
6. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
Li R; Shi X; Ling F; Wang C; Liu J; Wang W; Li M
Tumour Biol; 2015 Sep; 36(9):7277-83. PubMed ID: 25895459
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
[TBL] [Abstract][Full Text] [Related]
8. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS
Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347
[TBL] [Abstract][Full Text] [Related]
12. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
[TBL] [Abstract][Full Text] [Related]
13. miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer.
Li T; Li RS; Li YH; Zhong S; Chen YY; Zhang CM; Hu MM; Shen ZJ
J Urol; 2012 Apr; 187(4):1466-72. PubMed ID: 22341810
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
[TBL] [Abstract][Full Text] [Related]
15. Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.
Wang Y; Xia H; Zhuang Z; Miao L; Chen X; Cai H
Cell Death Dis; 2014 May; 5(5):e1227. PubMed ID: 24832599
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells.
Jiang L; Liu X; Chen Z; Jin Y; Heidbreder CE; Kolokythas A; Wang A; Dai Y; Zhou X
Biochem J; 2010 Nov; 432(1):199-205. PubMed ID: 20819078
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
